newsfilter
← Latest News
GlobeNewswire·

CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®

CLEVELAND, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced that the